CV Sciences (CVSI) Non-Current Assets (2013 - 2026)

CV Sciences (CVSI) reported Non-Current Assets of $1.7 million for Q1 2026, down 3.95% on a YoY basis from $1.8 million in Q1 2025, and down 5.58% sequentially from $1.8 million in Q4 2025.

CV Sciences (CVSI) Non-Current Assets (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 14 years of Non-Current Assets data on file, last reported at $1.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 3.95% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 1067.83% YoY), and the FY2025 full-year result was $1.8 million, up 8.61% from the prior year.
  • Non-Current Assets declined to $1.7 million in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $3.2 million in Q1 2022 to a low of -$6.4 million in Q3 2024.
  • A 5-year average of $1.4 million and a median of $1.7 million in 2026 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets sank 637.05% in 2024 and surged 129.62% in 2025, its largest moves.
  • Tracing CVSI's Non-Current Assets over 5 years: stood at $1.6 million in 2022, then dropped by 21.42% to $1.3 million in 2023, then jumped by 33.44% to $1.7 million in 2024, then grew by 8.61% to $1.8 million in 2025, then dropped by 5.58% to $1.7 million in 2026.
  • Business Quant data shows CVSI's Non-Current Assets at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn 1.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.73 Mn
Dec 31, 2025 1.83 Mn
Sep 30, 2025 1.90 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 1.80 Mn
Dec 31, 2024 1.68 Mn
Sep 30, 2024 -6.41 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.19 Mn
Jun 30, 2023 1.33 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.61 Mn
Sep 30, 2022 2.98 Mn
Jun 30, 2022 3.12 Mn
Mar 31, 2022 3.21 Mn
Dec 31, 2021 3.88 Mn
Sep 30, 2021 9.40 Mn
Jun 30, 2021 12.78 Mn